In July, the World Health Organization (WHO) published the Intersectoral global action plan on epilepsy and other neurological disorders (IGAP) in all six UN languages.
The IGAP, adopted by WHO Member States in May 2022, aims to improve access to treatment and care and quality of life of people with neurological disorders, their carers and families as well as promote brain health across the life-course. It includes actions to be undertaken by all stakeholders to attain the global targets.
The strategic objectives of the global action plan address issues such as policy and governance; effective, timely and responsive diagnosis, treatment and care; promotion and prevention; research, innovation and information systems; and a public health response to epilepsy.
The EAN (European Academy of Neurology) is actively working towards and collaborating with various stakeholders to enhance the implementation of the IGAP and it’s strategic goals. Through its extensive network of neurologists and researchers, the EAN is promoting research and knowledge exchange to improve the diagnosis and treatment of neurological disorders, contributing to the IGAP’s aim of enhancing access to treatment and care for affected individuals. Furthermore, the EAN is organizing educational programs and awareness campaigns to promote brain health across different stages of life, aligning with IGAP’s focus on promoting brain health throughout the life-course.
